Abiopharma

The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform

Innoviz Technologies Launches InnovizTwo Ultra Long-Range (ULR) LiDAR, Delivering up to 1-Kilometer Sensing to Power Next-Generation Physical AI for Automotive and SMART Applications

IP Strategy Highlights the Story Global Wallet: Advancing Access to Programmable IP Infrastructure

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

LiveOne (Nasdaq: LVO) Eliminates $15M+ Short-Term Liabilities, Delivering $13M+ in Cash Savings; Expands Stock Conversion Program to $15M+ at $7.50 per Share, with $8M Completed

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

PMV Pharmaceuticals Announces Board Chair Transition

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

Ascend Wellness Holdings Announces the Opening of East Coasting Dispensary in Eatontown, New Jersey

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

Las Vegas Metropolitan Police Signs Five-Year WrapReality™ Contract Renewal with WRAP® to Advance Immersive Training and Non-Lethal Response™ Preparedness

Arteris to Announce Financial Results for the First Quarter 2026 on Tuesday, May 12, 2026